Growth Metrics

Zoetis (ZTS) Asset Writedowns and Impairment (2016 - 2026)

Zoetis has reported Asset Writedowns and Impairment over the past 14 years, most recently at $29.0 million for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 172.5% to $29.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.0 million through Dec 2025, up 400.0% year-over-year, with the annual reading at $68.0 million for FY2025, 119.35% up from the prior year.
  • Asset Writedowns and Impairment was $29.0 million for Q4 2025 at Zoetis, up from $22.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $46.0 million in Q4 2022 and troughed at -$40.0 million in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $12.0 million (2023), against an average of $10.9 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 1600.0% in 2024 against a maximum downside of 310.53% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $11.0 million in 2021, then skyrocketed by 318.18% to $46.0 million in 2022, then tumbled by 58.7% to $19.0 million in 2023, then crashed by 310.53% to -$40.0 million in 2024, then skyrocketed by 172.5% to $29.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Asset Writedowns and Impairment are $29.0 million (Q4 2025), $22.0 million (Q2 2025), and $18.0 million (Q1 2025).